Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Chicago GlaxoSmithKline |
---|---|
Information provided by: | University of Chicago |
ClinicalTrials.gov Identifier: | NCT00791973 |
The purpose of this study is to help us to a better understanding of how nose and eye symptoms are related in patients with allergies.
Condition | Intervention | Phase |
---|---|---|
Allergic Rhinitis |
Drug: fluticasone furoate Drug: fluticasone furoate placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen |
Estimated Enrollment: | 15 |
Study Start Date: | November 2008 |
Estimated Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
fluticasone furoate nasal spray once daily for a week
|
Drug: fluticasone furoate
2 puffs in each nostril once daily for 1 week
|
2: Placebo Comparator |
Drug: fluticasone furoate placebo
2 puffs in each nostril once daily for 1 week
|
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Marcy deTineo, BSN | 773-702-5889 |
United States, Illinois | |
University of Chicago Medical Center | |
Chicago, Illinois, United States, 60637 |
Principal Investigator: | Robert Naclerio, MD | University of Chicago |
Responsible Party: | University of Chicago ( Robert Naclerio, MD ) |
Study ID Numbers: | 16367B (OC 3) |
Study First Received: | November 13, 2008 |
Last Updated: | November 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00791973 |
Health Authority: | United States: Food and Drug Administration |
Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases Fluticasone Rhinitis |
Anti-Inflammatory Agents Respiratory System Agents Autonomic Agents Therapeutic Uses Physiological Effects of Drugs Anti-Asthmatic Agents |
Anti-Allergic Agents Peripheral Nervous System Agents Dermatologic Agents Bronchodilator Agents Pharmacologic Actions Nose Diseases |